Company: BIVIW
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001520138-25-000198
Chunk: 62

Company: BIOVIE INC.
Filing Date: 2025-07-03
Form: S-1
Chunk 62
---
 at https://bioviepharma.com/. Information found on, or accessible through, our website is
not a part of, and is not incorporated into, this prospectus, and you should not consider it part of this prospectus.

<div align='center'>Incorporation of
Documents by Reference</div>

The SEC allows us to incorporate by reference
the information we file with it, which means that we can disclose important information to you by referring you to another document that
we have filed separately with the SEC. You should read the information incorporated by reference because it is an important part of this
prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date
of this prospectus, while information that we file later with the SEC will automatically update and supersede the information in this
prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information
or documents listed below that we have filed with the SEC (Commission File No. 001-39015):

<div align='center'>38</div>

| · | the description                                                                                                                         
 of our Common Stock contained in our registration on Form 8-A (File No. 001-39015) filed with the SEC on August 25, 2020, including any 
 amendment or report filed for the purpose of updating such description.                                                                 |

We also incorporate by reference any future filings
(other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such
items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
Exchange Act, including those made after the date of the initial filing of the registration statement of which this prospectus is a part
and prior to effectiveness of such registration statement, until we file a post-effective amendment that indicates the termination of
this offering and will become a part of this prospectus from the date that such documents are filed with the SEC. Information in such
future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will automatically
be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be
incorporated herein by reference to the extent that statements